Clinical Study of CN128 in Thalassemia Patients

NCT03673085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia

Interventions

DRUG: CN128
OTHER: placebo

Sponsor

Hangzhou Zede Pharma-Tech Co., Ltd.